QuidelOrtho Corp
- Last sale
- Nov 12, 2026 · -10.87%
- Market cap
- $728.32M
- 68.61M shares
- Filings
- 504
Q3 2026−1.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+72.7% FY25 yoy
- $728.32M
- —
- 0.3×
- 0.4×
- -16.08%
- —
Twelve months to Sep 27, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-28 | $2,730,200,000 | reported | |
| FY 2024 | 2024-12-29 | $2,782,900,000 | reported | |
| FY 2023 | 2023-12-31 | $2,997,800,000 | reported | |
| FY 2022 | 2023-01-01 | $3,266,000,000 | reported | |
| FY 2021 | 2022-01-02 | $1,698,600,000 | reported | |
| FY 2020 | 2021-01-03 | $1,661,700,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $0.00 | $0.00 | — | 68.08M sh | +0.9% | — |
| FY2024 | — | $0.00 | $0.00 | — | 67.45M sh | +0.9% | — |
| FY2023 | — | $7.20M | $7.20M | — | 66.85M sh | +0.5% | 10.2% |
| FY2022 | — | $74.30M | $74.30M | — | 66.51M sh | +59.5% | 10.0% |
| FY2021 | — | $103.50M | $103.50M | — | 41.70M sh | — | 20.2% |
Segments
LineFY2025ShareChange
North America$1.49B55%−8.1%
EMEA$360.70M13%+7.4%
China$334.70M12%+3.0%
JPAC$293.00M11%+4.9%
Latin America$252.90M9.3%+13.5%
China———
Other———
Total$2.73B
In vitro & in vivo diagnostic substances
QuidelOrtho Corp is the 2nd largest of the 20 covered companies the SEC files under this code, by revenue. SIC 2835
CompanyRevenueGrowthNet marginMarket cap
IDXXIDEXX Laboratories Inc$4.3B10.4%24.6%$55.0B
QDELQuidelOrtho Corp (this company)$2.7B1.9%41.5%$728.3M
LNTHLantheus Holdings, Inc.$1.5B0.5%15.2%$6.6BNEOGNeogen Corp$870.4M2.7%0.9%$2.4BMYGNMyriad Genetics Inc$824.5M1.6%44.4%$544.8MNTLAIntellia Therapeutics, Inc.$67.7M16.9%609.9%$1.5BTKNOAlpha Teknova, Inc.$40.5M7.4%42.6%$521.8MICCCImmucell Corp$27.6M4.3%3.8%$89.6MAWHLAspira Women's Health Inc.$9.2M0.4%138.7%$16.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
QuidelOrtho Corp · CIK 1906324 · Engraved from SEC EDGAR